Ainos, Inc. (AIMD)
NASDAQ: AIMD · Real-Time Price · USD
2.550
-0.130 (-4.85%)
Jul 29, 2025, 11:45 AM - Market open

Company Description

Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics.

Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-readable data.

The company is also giving AI for robotics, smart factories, senior care, and women’s health. In addition, it develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases, plus applications in animal health.

The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021.

Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.

Ainos, Inc.
Ainos logo
CountryUnited States
Founded1984
IndustryMedical Devices
SectorHealthcare
Employees44
CEOChun-Hsien Tsai

Contact Details

Address:
8880 Rio San Diego Drive, Suite 800
San Diego, California 92108
United States
Phone858 869 2986
Websiteainos.com

Stock Details

Ticker SymbolAIMD
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001014763
CUSIP Number00902F402
ISIN NumberUS00902F3038
Employer ID75-1974352
SIC Code2834

Key Executives

NamePosition
Chun-Hsien TsaiChief Executive Officer, President and Chairman of the Board
Hsin-Liang LeeChief Financial Officer
Chih-Heng LuDirector of Corporate Developoment

Latest SEC Filings

DateTypeTitle
Jul 16, 20258-KCurrent Report
Jul 1, 20258-KCurrent Report
Jun 24, 20258-KCurrent Report
May 29, 2025DEF 14CFiling
May 19, 2025PRE 14CFiling
May 14, 202510-QQuarterly Report
May 12, 20258-KCurrent Report
Apr 11, 2025SCHEDULE 13DFiling
Apr 11, 2025SCHEDULE 13DFiling
Apr 9, 2025SCHEDULE 13D/AFiling